The IKS Care Enablement Platform enables them to deliver the chores of healthcare, across administrative, clinical, and operational burdens, to enable clinicians to focus on their core purpose: delivering great care and bringing joy and purpose back to medicine. They’re redefining the future of Care Enablement and creating transformative value in healthcare by empowering clinicians to build healthier communities and enabling stronger, financially sustainable enterprises.

Inventurus Knowledge Solutions, an Book Built Issue amounting to ₹2,497.92 Crores, consisting entirely an Offer for Sale of 187.95 Lakh Shares. The subscription period for the Inventurus Knowledge Solutions IPO opens on December 12, 2024, and closes on December 16, 2024. The allotment is expected to be finalized on or about Tuesday, December 17, 2024, and the shares will be listed on the BSE & NSE with a tentative listing date set on or about Thursday, December 19, 2024.

 

 

 

 

 

 

 

 

The Share price band of Inventurus Knowledge Solutions IPO is set at ₹1,265 to ₹1,329 per equity share. The Market Capitalisation of the Inventurus Knowledge Solutions Limited at IPO price of ₹1,329 per equity share will be ₹22,802.07 Crores. The lot size of the IPO is 11 shares. Retail investors are required to invest a minimum of ₹14,619, while the minimum investment for High-Net-Worth Individuals (HNIs) is 14 lots (154 shares), amounting to ₹2,04,666.

ICICI Securities Limited, Jefferies India Private Limited, Nomura Financial Advisory and Securities (India) Private Limited, JM Financial Limited and J.P. Morgan India Private Limited are the book-running lead manager while Link Intime India Private Limited is the registrar for the Issue. 

 

Inventurus Knowledge Solutions Limited IPO GMP Today
The Grey Market Premium of Inventurus Knowledge Solutions Limited IPO is expected to be ₹334 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Inventurus Knowledge Solutions Limited Day Wise IPO GMP Trend

Date	IPO Price	Expected Listing Price	GMP	Last Updated
13 December 2024	₹ 1,329	₹ 1,663	₹ 334 (25.11%)	05:30 PM; 13 Dec 2024
12 December 2024	₹ 1,329	₹ 1,663	₹ 334 (25.11%)	06:00 PM; 12 Dec 2024
11 December 2024	₹ 1,329	₹ 1,663	₹ 334 (25.11%)	06:00 PM; 11 Dec 2024
10 December 2024	₹ 1,329	₹ 1,548	₹ 219 (16.51%)	04:20 PM; 10 Dec 2024

Inventurus Knowledge Solutions Limited IPO Live Subscription Status Today: Real-Time Updates
As of 07:00 PM on 16 December 2024, the Inventurus Knowledge Solutions IPO live subscription status shows that the IPO subscribed 52.68 times on its Final day of subscription period. Check the Inventurus Knowledge Solutions IPO Live Subscription Status Today at BSE.

Inventurus Knowledge Solutions IPO Anchor Investors Report
Inventurus Knowledge Solutions has raised ₹1,120.18 Crores from Anchor Investors at a price of ₹1,329 per shares in consultation of the Book Running Lead Managers. The company allocated 84,28,730 equity shares to the Anchor Investors. Check Full List of Inventurus Knowledge Solutions Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion.

Inventurus Knowledge Solutions Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Inventurus Knowledge Solutions IPO allotment date is 17 December, 2024, Tuesday. Inventurus Knowledge Solutions IPO Allotment will be out on 17th December 2024 and will be live on Registrar Website from the allotment date. Check Inventurus Knowledge Solutions IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Inventurus Knowledge Solutions Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

 

Objectives of Inventurus Knowledge Solutions Limited IPO
Inventurus Knowledge Solutions will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

 

 

 

 

Refer to Inventurus Knowledge Solutions Limited RHP for more details about the Company.

Check latest IPO Review & analysis, Live IPO GMP today, Live IPO Subscription Status Today, Share Price, Financial Information and other details before applying in the IPO.

The Upcoming IPOs in this week and coming weeks are Jungle Camps, Toss The Coin, Sai Life Sciences, Mobikwik, Vishal Mega Mart, Supreme Facility, Purple United, Yash Highvoltage, International Gemmological, Inventurus Knowledge, Rosmerta Digital and Avanse Financial.

The Current active IPO is Dhanlaxmi Corp and Emerald Tyre Manufacturers.

The Closed IPOs are  Nisus Finance, Ganesh Infraworld, Suraksha Diagnostic, Agarwal Toughened.

The Recently Listed IPOs which is available for trading in stock Market are Apex Ecotech, Rajputana Biodiesel, Rajesh Power Services, C2C Advanced System, Enviro Infra Engineers, Waaree Energies Limited IPO, Diffusion Engineers Limited IPO, KRN Heat Exchanger Limited IPO, P N Gadgil Jewellers Limited IPO, Bajaj Housing Finance Limited IPO, Gala Precision Engineering Limited IPO, Premier Energies Limited IPO, Orient Technologies Limited IPO, Interarch Building Products Limited IPO, Unicommerce eSolutions Limited IPO and many more.

Read more

About Inventurus Knowledge Solutions Limited

Business Overview

Inventurus Knowledge Solutions Limited (IKS Health), incorporated in Goa, India, on September 5, 2006, is a technology-driven provider of healthcare solutions. IKS Health operates a care enablement platform designed to support U.S.-based healthcare organisations, including hospital-owned and independent medical groups, as well as other outpatient groups. The company's focus is on addressing the financial, clinical, and operational needs of these organisations. IKS Health's registered office is located in Navi Mumbai, Thane, Maharashtra.

A significant milestone for IKS Health was the acquisition of Aquity Holdings, Inc. (Aquity Holdings) on October 27, 2023. This acquisition, achieved through a scheme of merger, expanded IKS Health's operational reach and service portfolio. Aquity Holdings, a Delaware corporation established on December 10, 2018, encompasses subsidiaries such as Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Ltd, and Aquity Canada ULC. These subsidiaries operate in key markets, strengthening IKS Health's global presence.

Industry Analysis

The U.S. healthcare sector, specifically the market for technology-enabled solutions targeted at healthcare providers, is experiencing significant growth. This growth is fueled by the increasing demand for efficient and effective solutions to manage the complexities of the U.S. healthcare system. IKS Health, with its expertise in delivering a diverse range of solutions across the healthcare value chain, is well-positioned to capitalise on these growth opportunities.

The industry is characterized by competition from companies like R1 RCM and Augmedix. However, these competitors often focus on specific areas like Revenue Cycle Management or Clinical Documentation. IKS Health's competitive edge lies in its broader approach, offering a wider array of services that cater to the diverse needs of healthcare providers. This comprehensive suite of solutions allows IKS Health to stand out in the competitive landscape.

Business Strengths

Core Competencies: IKS Health's key strengths are rooted in its extensive domain knowledge, its investment in advanced technological solutions, and its commitment to delivering high-quality clinical services. The company's deep understanding of the U.S. healthcare system and its ability to leverage technology to address the challenges faced by healthcare providers are integral to its success.

Unique Selling Propositions (USPs): IKS Health's USP is its ability to empower healthcare providers to optimise their operations, enhance the quality of care they deliver, and achieve sustainable growth in the face of a constantly evolving healthcare environment. By offering tailored solutions that combine technology, expertise, and a focus on patient outcomes, IKS Health differentiates itself in the market.

Competitive Advantages: IKS Health's competitive advantages include its comprehensive service offerings, innovative technology platform, and strategic focus on delivering tangible value to its clients. The company's commitment to continuous improvement and expansion into new service areas further strengthens its market position.

Business Strategies

IKS Health's growth strategy centres around providing tailored solutions that cater to the specific needs of healthcare providers. The company leverages its technological prowess to improve operational efficiency, reduce costs, and enhance patient care. This client-centric approach, coupled with a dedication to innovation, forms the foundation of IKS Health's growth strategy.

IKS Health is also committed to driving innovation by developing new and advanced solutions that effectively address emerging challenges within the healthcare industry. The company's proactive approach to innovation ensures it remains a relevant and valuable partner to healthcare providers as the industry continues to evolve.

Risk Factors and Concerns

FEMA Compliance: IKS Health has a documented history of non-compliance with the Foreign Exchange Management Act (FEMA) due to partly paid-up share allotments to non-resident individuals without prior government approval. While post-facto approval was granted, a compounding application filed with the RBI on July 30, 2024, remains pending. The resolution of this application carries significant weight as unfavourable outcomes could lead to regulatory penalties, compounding fees, or even the revocation of the partly paid-up allotments. Such a scenario would undoubtedly impact IKS Health's regulatory standing and investor confidence.

Client Concentration: IKS Health's revenue stream is significantly reliant on a limited number of clients. In Fiscal 2024, the top 10 clients accounted for 67.09% of the company's total revenue. The loss of one or more of these key clients could deal a substantial blow to IKS Health's financial performance. This risk is amplified by the absence of guaranteed contract renewals and the inherent sensitivity of client relationships in the healthcare industry to performance and market dynamics.

U.S. Market Dependency: IKS Health derives the majority of its revenue from healthcare organisations operating in the United States. This heavy dependence on a single geographical market exposes the company to several risks, including:

• Shifts in U.S. healthcare regulations and policies, which could impact IKS Health's service offerings and business practices.
• Economic downturns or instability in the U.S. market, which could affect the financial health of IKS Health's clients and, consequently, their demand for the company's services.
• Intensifying competition from established and emerging healthcare solution providers within the U.S. market, potentially leading to pricing pressure and reduced market share.

Data Security and Privacy: IKS Health manages sensitive medical data, including patient records and financial information. This data handling subjects the company to rigorous data privacy regulations like HIPAA in the U.S. and GDPR globally. Any data breach or non-compliance with these stringent regulations could expose IKS Health to substantial financial penalties, reputational damage, and legal actions.

Integration Challenges: Following the acquisition of Aquity Holdings, IKS Health faces the challenge of successfully integrating Aquity's operations, systems, and personnel into its existing structure. The effective management of this integration process is critical for IKS Health to realise the anticipated benefits of the acquisition. Failure to achieve a seamless integration could result in operational disruptions, financial losses, and difficulties in capturing the expected synergies from the acquisition.

Key Personnel Reliance: IKS Health's success is heavily dependent on its senior management and core personnel, who possess specialised knowledge and experience in healthcare technology. The loss of key individuals or an inability to attract and retain skilled talent could significantly impact the company's operations, its capacity for innovation, and its overall performance.

Currency Fluctuations: IKS Health receives payments in U.S. dollars while incurring a significant portion of its expenses in Indian rupees. This situation exposes the company to fluctuations in foreign exchange rates. Unfavourable currency movements could negatively impact IKS Health's profitability and financial performance.

Industry-Specific Challenges: The U.S. healthcare industry faces various challenges, including:

• Mounting pressure to reduce healthcare costs while maintaining high-quality care.
• The inherent complexity of the U.S. healthcare system and the evolution of reimbursement models.
• Growing cybersecurity threats and increasing concerns over data privacy.
• Rapid technological advancements that necessitate continuous innovation and adaptation to remain competitive.

These industry-wide challenges could potentially impact IKS Health's growth prospects and profitability.